CD33 MicroBeads, human

Name: CD33 MicroBeads, human
Availability: InStock

CD33 MicroBeads, human

CD33 MicroBeads have been developed for separation of cells based on the expression of the CD33 antigen. CD33

⁺

cells can be enriched from PBMCs, bone marrow¹

^,

², or tissues.³

Product data and images for CD33 MicroBeads, human

Figures

Figure 1

Separation of CD33

⁺

cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.

PBMCs before separation	Isolated CD33 ⁺ cells
View details CD33 MicroBeads, human Figure 1 Separation of CD33 ⁺ cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.	View details CD33 MicroBeads, human Figure 1 Separation of CD33 ⁺ cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.

Specifications for CD33 MicroBeads, human

Overview

CD33 MicroBeads have been developed for separation of cells based on the expression of the CD33 antigen. CD33

⁺

cells can be enriched from PBMCs, bone marrow¹

^,

², or tissues.³

Detailed product information

Background information

The CD33 antigen is brightly expressed on monocytes and dimly on granulocytes and dendritic cells. The CD33 antigen is also found on myeloid progenitor cells but is not expressed on lymphocytes, platelets, erythrocytes, and primitive hematopoietic stem cells.

Applications

CD33

⁺

cells can be enriched from PBMCs, bone marrow

^1,2

, or tissues.

³

Additionally, the CD33 antigen can be used to distinguish acute myeloid leukemias from lymphoblastic leukemias.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

References for CD33 MicroBeads, human

Publications

Czerniecki, B. J. et al. (1997) Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159: 3823-3837
Gonzalez, R. et al. (1999) Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum. Gene Ther. 10: 2709-2717
Rogler, G. et al. (1998) Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112: 205-215

Data and images

Data and images for CD33 MicroBeads, human

Figures

Figure 1

Separation of CD33

⁺

cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.

PBMCs before separation	Isolated CD33 ⁺ cells
View details CD33 MicroBeads, human Figure 1 Separation of CD33 ⁺ cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.	View details CD33 MicroBeads, human Figure 1 Separation of CD33 ⁺ cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.

Specifications

Specifications for CD33 MicroBeads, human

Overview

CD33 MicroBeads have been developed for separation of cells based on the expression of the CD33 antigen. CD33

⁺

cells can be enriched from PBMCs, bone marrow¹

^,

², or tissues.³

Detailed product information

Background information

The CD33 antigen is brightly expressed on monocytes and dimly on granulocytes and dendritic cells. The CD33 antigen is also found on myeloid progenitor cells but is not expressed on lymphocytes, platelets, erythrocytes, and primitive hematopoietic stem cells.

Applications

CD33

⁺

cells can be enriched from PBMCs, bone marrow

^1,2

, or tissues.

³

Additionally, the CD33 antigen can be used to distinguish acute myeloid leukemias from lymphoblastic leukemias.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

References

References for CD33 MicroBeads, human

Publications

Czerniecki, B. J. et al. (1997) Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159: 3823-3837
Gonzalez, R. et al. (1999) Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum. Gene Ther. 10: 2709-2717
Rogler, G. et al. (1998) Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112: 205-215

Related products for
CD33 MicroBeads, human

4 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?

Contact

Contact

CD33 MicroBeads, human

CD33 MicroBeads, human

Product data and images for CD33 MicroBeads, human

Figures

Figure 1

Figure 1

Figure 1

Specifications for CD33 MicroBeads, human

Overview

Detailed product information

Background information

Applications

Columns

References for CD33 MicroBeads, human

Publications

Data and images

Data and images for CD33 MicroBeads, human

Figures

Figure 1

Figure 1

Figure 1

Specifications

Specifications for CD33 MicroBeads, human

Overview

Detailed product information

Background information

Applications

Columns

References

References for CD33 MicroBeads, human

Publications

Related products for
CD33 MicroBeads, human

4 products available

Shop

Careers

About Miltenyi Biotec

Contact

CD33 MicroBeads, human

CD33 MicroBeads, human

Product data and images for CD33 MicroBeads, human

Figures

Figure 1